Seres Therapeutics MCRB
NASDAQ MCRB
$2.34 +0.03 (+1.30%)
As of: Oct 21, 2026 · 11:26 AM EDT

Seres Therapeutics (MCRB) Notes Payables (2014 - 2022)

Updated

Seres Therapeutics' Notes Payables was $456,000 in Q4 2022.

Analysis

Seres Therapeutics (MCRB) Notes Payables (2014 - 2022) Analysis & Trends

From Q4 2014 onward, Seres Therapeutics has reported Notes Payables for 7 quarters.

  • In earlier years, Notes Payables was $454,000 in FY2020.
  • The Q4 2022 figure marks the highest quarterly Notes Payables since Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Seres Therapeutics 22.71 Mn -116.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 456,000.00
Sep 30, 2021 9.35 Mn
Jun 30, 2021 6.30 Mn
Mar 31, 2021 3.34 Mn
Dec 31, 2020 454,000.00
Jun 30, 2015 1.20 Mn
Dec 31, 2014 1.20 Mn
API Access

Seres Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=MCRB&period=max&api_key=YOUR_API_KEY